tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NTBL Stock Latest News

Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
Press ReleasesNotable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
1d ago
NTBL
Notable Labs receives FDA clearance to proceed further with volasertib study
PremiumThe Fly
Notable Labs receives FDA clearance to proceed further with volasertib study
1d ago
NTBL
Notable Labs files to sell 19.74M ordinary shares, pre-funded warrants
PremiumThe Fly
Notable Labs files to sell 19.74M ordinary shares, pre-funded warrants
1M ago
NTBL
Notable Labs Unveils Strategic Outlook in Business Update
PremiumCompany Announcements
Notable Labs Unveils Strategic Outlook in Business Update
2M ago
8K
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe Fly
Notable Labs management to meet with Maxim Group
2M ago
NTBL
Notable Labs price target lowered to $5 from $7 at Chardan
PremiumThe FlyNotable Labs price target lowered to $5 from $7 at Chardan
2M ago
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe Fly
Notable Labs management to meet with Maxim Group
2M ago
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe Fly
Notable Labs management to meet with Maxim Group
2M ago
NTBL
Notable Labs management to meet with Maxim Group
PremiumThe Fly
Notable Labs management to meet with Maxim Group
2M ago
NTBL
Notable Labs Shares Strategic Insights in Business Overview
PremiumCompany Announcements
Notable Labs Shares Strategic Insights in Business Overview
3M ago
8K
NTBL
Notable Labs price target lowered to $7 from $9 at Chardan
PremiumThe Fly
Notable Labs price target lowered to $7 from $9 at Chardan
3M ago
NTBL
Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
PremiumCompany Announcements
Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
3M ago
NTBL
Notable Labs sees cash runway into 4Q24
PremiumThe FlyNotable Labs sees cash runway into 4Q24
3M ago
NTBL
Notable Labs reports 2023 EPS ($3.41) vs. ($21.97) last year
PremiumThe Fly
Notable Labs reports 2023 EPS ($3.41) vs. ($21.97) last year
3M ago
NTBL
Notable Labs Reports 2023 Financial Results and Provides a Business Update
PremiumPress Releases
Notable Labs Reports 2023 Financial Results and Provides a Business Update
3M ago
NTBL
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
PremiumPress Releases
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
4M ago
NTBL
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
PremiumPress Releases
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
4M ago
NTBL
Two new option listings and option delistings on March 25th
PremiumThe Fly
Two new option listings and option delistings on March 25th
4M ago
AQB
GNS
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
PremiumPress Releases
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
5M ago
NTBL
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
PremiumPress ReleasesNotable Labs to Present Two Posters at AACR 2024 on PPMP Platform
5M ago
NTBL
Notable Labs Advances Phase 2 Trial for Volasertib
PremiumCompany Announcements
Notable Labs Advances Phase 2 Trial for Volasertib
5M ago
8K
NTBL
Notable Labs advances volasertib Phase 2 program
PremiumThe Fly
Notable Labs advances volasertib Phase 2 program
5M ago
NTBL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >